A Sober Look At This Psychedelic Stock
Amid growing acceptance of the use of psychedelic drugs for treating mental disorders, the clinical-stage biotech company featured in today’s article, which has a pipeline…
Clinical-Stage Biotechs
Why These 2 Overlooked Biotech Stocks Are Deserving Of Attention
“Both of these biotechs deserve a lot more attention than they’ve been receiving,” asserts the author of today’s article in regards to two clinical-stage biotech…
Product Candidates For Wet Underarms And Dry Eyes Have These 2 Stocks Dripping With Upside Potential
Product candidates for the treatment of excessive underarm sweating on one hand, and dry eye disease on the other, could help the two stocks highlighted…
This Preclinical Biotech Is Going Clinical This Year – And Goldman Says It’s A Buy
Today’s article highlights a biotech firm that, after being relatively quiet for several years, the market may begin to take notice of as it goes…
These 2 Biotechs Could Revolutionize Disease Treatment And Prevention – And Bring Big Rewards To Risk-Tolerant Investors
“One method of finding great stocks is to hunt down clinical stage companies with potential new treatment methods for diseases and ailments that affect large…